Abstract
Changes within the glycosylation profile of cancer cells have been unequivocally associated with cancer movement. To extend our experiences into the part of glycosylation in human pancreatic ductal adenocarcinoma (PDAC), we performed a ponder on O-glycans and glycosphingolipid (GSL) glycans of the PDAC cell lines Pa-Tu-8988T (PaTuT) and Pa-Tu-8988S (PaTu-S). These cell lines are determined from the same understanding, but appear an nearly inverse phenotype, morphology and capacity to metastasize, and may in this way give an appealing demonstrate to ponder the part of glycosylation in movement of PDAC. Gene-array examination uncovered that 24% of the glycosylation-related qualities appeared a ≥ 1.5-fold distinction in expression level between the two cell lines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
